BOLT (boltbio.com) Net Profit
Bolt Biotherapeutics profitability is constrained by logistical complexities and patent disputes in Asia. The company's annual net income clearly illustrates current efficiency, where the -0.03 mark characterizes this parameter. Partnerships with Roche and ISAC drug trials are driving share price growth. However, a high dependence on a narrow oncology pipeline creates binary risks, which are mitigated by the support of major pharmaceutical partners.
Analytical breakdowns and data insights for company boltbio.com (BOLT)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Bolt Biotherapeutics|BOLT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Bolt Biotherapeutics, Inc.|BOLT - Company Total Debt|Debts to Book Capitalization Bolt Biotherapeutics|BOLT - Company Long-Term Debt|Company Short-Term Indebtedness Bolt Biotherapeutics|Immediate Liquidity boltbio.com
- net income and valuation multiples indicators:
Summary company analysis:Bolt Biotherapeutics
The aggregate financial performance of Bolt Biotherapeutics (BOLT) reflects the efficiency of monetizing biotechnological developments net of all operating expenses. This indicator measures the net remaining funds after covering R&D costs, where the high burn rate of capital for clinical trials and the uncertainty of therapy outcomes directly determine profit volatility and the overall investment stability of the asset.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR: Company Net Income|Nektar Therapeutics (NKTR) - Company Net Income|Company Net Income upstreambio.com (UPB)|Company Net Income Zenas Biopharma|Company Net Income IMNM|Net Income GOSS (Gossamer Corp)|Profit After Payment of Taxes KALV|Septerna Inc - Net Income|Final Profit PVLA|Savara - Net Profit|RIGL: Company Net Income|ANAB: Net Profit|ATXS - Net Financial Result|Company Net Income enGene Holdings Inc.|Company Net Income rapt.com RAPT|Net Income JBIO (Aerovate Therapeutics Inc)|Profit After Payment of Taxes ACRS|Net Profit KYTX (Kyverna)|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|Company Net Income ventyxbio.com|Theratechnologies (THTX) - Company Net Income|Avalo Therapeutics, Inc. - Final Profit|ELDN (Eledon) - Net Profit|Net Profit Agenus, Inc|Company Net Income Climb Bio Inc (CLYM)|ZURA: Profit After Tax|Net Profit ATYR (aTyr Pharma)|Adagene Inc (ADAG) - Company Net Income|IMA: Net Income|STTK - Net Profit|EQ (equilliumbio.com) - Net Income|CNTB: Profit After Payment of Taxes|IMUX (Immunic Therapeutics) - Net Profit|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Net Profit IFRX|Net Income X4 Pharmaceuticals, Inc XFOR|Company Net Income Adicet Bio, Inc. ACET|Net Financial Result Celularity Inc (CELU)|INmune Bio - Net Profit|BRNS: Company Net Income|Kezar Life Sciences, Inc (KZR) - Company Net Income|Company Net Income SAB Biotherapeutics Inc (SABS)|Company Net Income Akari Therapeutics|Company Net Income ENLV|Net Income QTTB (Q32 Bio Inc.)|Profit After Payment of Taxes GOVX|Company Net Income Edesa EDSA|IBIO (iBio Corporation) - Profit After Tax|Carisma Tx - Net Profit|Final Profit XTLB (xtlbio.com)|HCWB: Net Profit|Aptevo Therapeutics Inc. (APVO) - Net Profit|Company Net Income AIM ImmunoTech|ADTX: Final Profit|Company Net Income GRI Bio, Inc. (GRI)|Net Income xortx.com XRTX|Net Profit HIND (Vyome Holdings)|Net Profit Revelation Biosciences Inc REVB|INDP: Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|CALI: Net Profit|AFMD - Net Financial Result|Company Net Income Allakos Inc|Net Income HOOKIPA (HOOK)|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Ocean Biomedical, Inc. - Net Income|Net Profit tcbiopharm.com TCBP|THRD - Company Net Income